Clinuvel PharmaceuticalsCUV 
$10.13-1.19%24h
-1.19%24h
Global rank11332
Market cap$500.75M
Change 7d10.88%
YTD Performance-6.43%
SP500 benchmarkUnderperform
P/E17.15
P/S9.45
Revenue$52.99M
Earnings$20.71M
Dividend yield-
Main Sector
Healthcare
Category
Clinuvel Pharmaceuticals CUV Total Debt
CUV Total Debt in 2022: $472.91K
According to Clinuvel Pharmaceuticals latest financial reports the total debt is $472.91K, an decrease of -25.75% to 2022. At the end of 2022 company had $636.93K total debt. This figure represents the debts and financial obligations that Clinuvel Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Clinuvel Pharmaceuticals CUV Total Debt History from 2023 to 2022
-
Value:-
CUV Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $472.91K | -25.75% |
| 2022 | $636.93K | -9.93% |
| 2021 | $707.14K | -5.60% |
| 2020 | $749.08K | 546.49% |
| 2019 | $115.87K | - |
View the Top Total Debt Stocks 
